期刊文献+

Suppression of Growth of Hela, EJ, SK-OV-3 and MDA-MB-231 Cells by Recombinant Human NK4 被引量:2

Suppression of Growth of Hela,EJ,SK-OV-3 and MDA-MB-231 Cells by Recombinant Human NK4
下载PDF
导出
摘要 Objective: To study the effects of recombinant human Nk4 on the growth and invasion activities of tumor cells. Methods: The inhibition of recombinant human NK4 on human oophoroma, cervical tumor, breast tumor and gallbladder tumor cells was evaluated in vitro by basement membrane invasion assay. Results: rhNK4 could markedly inhibited the growth of human oophoroma, cervical tumor and breast tumor cells. The inhibition rates of human oophoroma, cervical tumor, breast tumor and gallbladder tumor cells were 48.2%, 29.2%, 58.4% and 30.1% respectively. Conclusion: rhNK4 factor can markedly inhibit the invasion of multiple tumor cells. Objective: To study the effects of recombinant human Nk4 on the growth and invasion activities of tumor cells. Methods: The inhibition of recombinant human NK4 on human oophoroma, cervical tumor, breast tumor and gallbladder tumor cells was evaluated in vitro by basement membrane invasion assay. Results: rhNK4 could markedly inhibited the growth of human oophoroma, cervical tumor and breast tumor cells. The inhibition rates of human oophoroma, cervical tumor, breast tumor and gallbladder tumor cells were 48.2%, 29.2%, 58.4% and 30.1% respectively. Conclusion: rhNK4 factor can markedly inhibit the invasion of multiple tumor cells.
机构地区 Tumor Institute
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2009年第1期28-31,共4页 中国癌症研究(英文版)
关键词 rhNK4 Tumor cells In vitro invasion rhNK4 Tumor cells In vitro invasion
  • 相关文献

参考文献2

二级参考文献13

  • 1赖人旭,袁世珍,Toshikazu Nakamura.转染NK4基因对人胰腺癌SW1990细胞生物学特性的影响[J].癌症,2004,23(10):1134-1138. 被引量:3
  • 2Date K, Matsumoto K, Shimura H, et al. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor [J]. FEBS Lett, 1997,420( 1 ): 1-6. 被引量:1
  • 3van der Voort R, Taher TE, Derksen PW, et al. The hepatocyte growth factor/Met pathway in development,tumorigenesis, and B-cell differentiation [J]. Adv Cancer Res,2000,79: 39-90. 被引量:1
  • 4Parr C, Jiang WG. Hepatocyte growth factor activators,inhibitors and antagonists and their implication in cancer intervention [ J ]. Histol Histopathol, 2001,16 ( 1 ): 251-268. 被引量:1
  • 5Matsumoto K, Nakamura T. NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics [J]. Cancer Sci,2003,94(4): 321-327. 被引量:1
  • 6el-Kamar FG, Grossbard ML, Kozuch PS. Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative care[J]. Oncologist, 2003,8( 1 ): 18-34. 被引量:1
  • 7Fisher WE, Berger DH. Angiogenesis and antiangiogenic strategies in pancreatic cancer [J]. Int J Gastrointest Cancer,2003,33 ( 1 ): 79-88. 被引量:1
  • 8Kuba K, Matsumoto K, Date K, et al. HGF/NK4, a fourkringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice [J]. Cancer Res, 2000,60 (23):6737-6743. 被引量:1
  • 9Lucas R, Holmgren L, Garcia I, et al. Multiple forms of angiostatin induce apoptosis in endothelial cells [J]. Blood,1998,92(12) :4730-4741. 被引量:1
  • 10Heideman DA, van Beusechem VW, Bloemena E, et al.Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4 [J]. J Gene Med, 2004,6(3):317-327. 被引量:1

共引文献6

同被引文献18

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部